Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5842489 | Life Sciences | 2012 | 6 Pages |
Abstract
Previous studies demonstrate that the endothelin pathway is associated with vasculopathy, neuronal injury and inflammation in ECM. As demonstrated here, components of the ET-1 pathway may be important targets for adjunctive therapy in ECM, and may help in preventing hemorrhage and in improving survival when used as adjunctive therapy during malaria infection. The data presented suggest that our novel agent, HJP-272, may ameliorate alterations in the vasculature which can potentially lead to inflammation, neurological dysfunction, and subsequent death in mice with ECM.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Minxian Dai, Brandi Freeman, Fernando P. Bruno, Henry J. Shikani, Herbert B. Tanowitz, Louis M. Weiss, Sandra E. Reznik, Ralph A. Stephani, Mahalia S. Desruisseaux,